Supply and Delivery of Various Medical Supplies
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Embassy Manila is soliciting proposals for the Supply and Delivery of Various Medical Supplies to support a local medical mission in Pasay, Philippines. This Request for Quotation (RFQ) is for a Firm Fixed-Price contract. Proposals are due March 26, 2026, at 1:00 p.m. (Philippine local time).
Scope of Work
This opportunity requires the supply and delivery of a comprehensive range of medical and dental supplies, including pharmaceuticals, equipment, and general supplies. Detailed technical specifications, quantities, and "or equivalent" options are provided in the attached A001 Technical Specifications sheet. Deliveries are scheduled in five distinct batches, with the final batch due by April 30, 2026, to the Embassy Seafront Compound Warehouse in Pasay, Philippines. Standard packaging and a minimum shelf life of 1-2 years from delivery are required.
Contract Details
- Type: Request for Quotation (RFQ), Firm Fixed-Price, VAT-Exempt.
- Payment: Electronic Fund Transfer (EFT) within 30 days of receipt of statement of account.
- Set-Aside: None specified.
- Compliance: Offerors must comply with NDAA requirements and specific FAR clauses incorporated by reference, including 52.204-24, 52.204-25, 52.204-26 (Telecommunications and Video Surveillance), 52.212-3 (Offeror Representations and Certifications), and 52.212-4 (Contract Terms and Conditions). Vendors with actions over $40K must be registered in the System for Award Management (SAM).
Submission Requirements
Offerors must submit:
- A fully completed and signed Standard Form (SF-18).
- The complete Technical Specifications (Excel File) including Unit Cost and remarks.
- Completed FAR/DOSAR Clauses.
- A minimum of two (2) recent contracts for similar requirements completed within the past three years, including customer contact information, timelines, and performance outcomes. Vendors without similar contracts must submit a written statement demonstrating their ability to meet delivery requirements.
- Proof/statement confirming their capability to fulfill the order on time and according to instructions/delivery schedule. All offers must be in English.
Key Clarifications
Recent clarifications indicate less stringent requirements for this procurement:
- Pharmaceuticals: Not required to be "Made in USA." FDA DSCSA compliance and a U.S. pharmaceutical license are NOT required, as supplies are for Philippine nationals.
- Generics/Origin: Generic or equivalent products of equal or higher quality are acceptable. The origin of pharmaceuticals (e.g., China) is not a disqualifying factor.
- GLN: A Global Location Number (GLN) is NOT required from the offeror.
- Shelf Life: Pharmaceuticals should have a minimum remaining shelf life of 1-2 years from the date of delivery.
Submission & Deadline
- Deadline: March 26, 2026, no later than 1:00 p.m. (Philippine local time).
- Method: Electronic submissions via email to ManilaPurchasing@state.gov.
- Format: MS-Word, MS-Excel, or Adobe Acrobat (PDF) file format.
- File Size: Must not exceed 10MB per email; larger submissions require separate emails.
Evaluation
Award will be made to responsible offerors. Incomplete offers will not be accepted. Evaluation of foreign currency offers will be conducted using the U.S. Embassy Exchange Rate.